Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Harms JS, Durward MA, Magnani DM, Splitter GA.

J Immune Based Ther Vaccines. 2009 Jan 6;7:1. doi: 10.1186/1476-8518-7-1.

PMID:
19126207
[PubMed]
Free PMC Article
2.
3.

Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein.

Al-Mariri A.

Vaccine. 2010 Feb 17;28(7):1766-70. doi: 10.1016/j.vaccine.2009.12.012. Epub 2009 Dec 28.

PMID:
20036752
[PubMed - indexed for MEDLINE]
4.

The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.

Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, Oliveira SC, Warzecha H, Giambartolomei GH, Cassataro J.

J Immunol. 2010 May 1;184(9):5200-12. doi: 10.4049/jimmunol.0902209. Epub 2010 Mar 29.

PMID:
20351187
[PubMed - indexed for MEDLINE]
Free Article
5.

Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.

Vemulapalli R, He Y, Boyle SM, Sriranganathan N, Schurig GG.

Infect Immun. 2000 Jun;68(6):3290-6.

PMID:
10816476
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.

Infect Immun. 2009 Jan;77(1):436-45. doi: 10.1128/IAI.01151-08. Epub 2008 Nov 3. Erratum in: Infect Immun. 2009 Apr;77(4):1719.. Samartino, Clara García [corrected to García Samartino, Clara].

PMID:
18981242
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.

Cavanagh D.

Avian Pathol. 2003 Dec;32(6):567-82. Review.

PMID:
14676007
[PubMed - indexed for MEDLINE]
8.

Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.

Mallick AI, Singha H, Khan S, Anwar T, Ansari MA, Khalid R, Chaudhuri P, Owais M.

Vaccine. 2007 Nov 14;25(46):7873-84. Epub 2007 Sep 20.

PMID:
17931756
[PubMed - indexed for MEDLINE]
9.

Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.

Mallick AI, Singha H, Chaudhuri P, Nadeem A, Khan SA, Dar KA, Owais M.

Vaccine. 2007 May 4;25(18):3692-704. Epub 2007 Jan 25.

PMID:
17296251
[PubMed - indexed for MEDLINE]
10.

Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells.

Surendran N, Hiltbold EM, Heid B, Sriranganathan N, Boyle SM, Zimmerman KL, Makris MR, Witonsky SG.

Vet Microbiol. 2011 Jan 10;147(1-2):75-82. doi: 10.1016/j.vetmic.2010.06.001. Epub 2010 Jun 10.

PMID:
20594772
[PubMed - indexed for MEDLINE]
11.

Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.

Dougan G, Hormaeche CE, Maskell DJ.

Parasite Immunol. 1987 Mar;9(2):151-60. Review.

PMID:
3106921
[PubMed - indexed for MEDLINE]
12.

Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.

Al-Mariri A, Mahmoud NH, Hammoud R.

Biologicals. 2012 Mar;40(2):140-5. doi: 10.1016/j.biologicals.2012.01.002. Epub 2012 Jan 30.

PMID:
22296786
[PubMed - indexed for MEDLINE]
13.

The innate immune response against Brucella in humans.

Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP.

Vet Microbiol. 2002 Dec 20;90(1-4):383-94. Review.

PMID:
12414158
[PubMed - indexed for MEDLINE]
14.

Heat-killed and γ-irradiated Brucella strain RB51 stimulates enhanced dendritic cell activation, but not function compared with the virulent smooth strain 2308.

Surendran N, Hiltbold EM, Heid B, Sriranganathan N, Boyle SM, Zimmerman KL, Witonsky SG.

FEMS Immunol Med Microbiol. 2010 Nov;60(2):147-55. doi: 10.1111/j.1574-695X.2010.00729.x. Epub 2010 Aug 31.

PMID:
20812951
[PubMed - indexed for MEDLINE]
16.

Killing of Brucella antigen-sensitized macrophages by T lymphocytes in bovine brucellosis.

Wyckoff JH 3rd, Potts RD.

Vet Immunol Immunopathol. 2007 Dec 15;120(3-4):148-59. Epub 2007 Aug 11.

PMID:
17904229
[PubMed - indexed for MEDLINE]
17.

Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo.

Surendran N, Hiltbold EM, Heid B, Akira S, Standiford TJ, Sriranganathan N, Boyle SM, Zimmerman KL, Makris MR, Witonsky SG.

Vaccine. 2012 Feb 14;30(8):1502-12. doi: 10.1016/j.vaccine.2011.12.036. Epub 2012 Jan 9.

PMID:
22234268
[PubMed - indexed for MEDLINE]
18.

Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.

Zhao Z, Li M, Luo D, Xing L, Wu S, Duan Y, Yang P, Wang X.

Vaccine. 2009 Aug 20;27(38):5214-9. doi: 10.1016/j.vaccine.2009.06.075. Epub 2009 Jul 9.

PMID:
19596411
[PubMed - indexed for MEDLINE]
19.

Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.

Fuerst TR, Stover CK, de la Cruz VF.

Biotechnol Ther. 1991;2(1-2):159-78.

PMID:
1845119
[PubMed - indexed for MEDLINE]
20.

Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development.

Cannella AP, Tsolis RM, Liang L, Felgner PL, Saito M, Sette A, Gotuzzo E, Vinetz JM.

Front Cell Infect Microbiol. 2012 Feb 1;2:1. doi: 10.3389/fcimb.2012.00001. eCollection 2012.

PMID:
22919593
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk